Dartford, Kent, United Kingdom (PRWEB UK) 6 June 2016 -- Popularity for laser hair therapy with mobile, at-home “laser caps” has skyrocketed over the past year. In the UK alone, thousands of men and women have taken to search engines and social media to learn more about this new method of non-surgical hair loss treatment. And while some are initially skeptical that low-level laser light can help to regrow hair, research on the history of low-level laser therapy (LLLT) reveals a long track record of success in various medical contexts since the 1960s.
“Being diagnosed with any type of hair loss is devastating, so for me choosing the best treatment protocol for my client’s hair and scalp health is paramount,” said Mandy Baldwin, BSc (Hons) MIT LTTS, founder of the Hair and Scalp Trichology Clinic in Dartford. “Since introducing the Capillus to my clients, I am delighted to say their feedback is absolutely positive. Capillus is producing remarkable results and is a great success.”
Capillus laser caps feature a dome shaped insert that discretely fits on the inside of an ordinary hat or head covering. The laser cap is battery-operated, allowing easy and hands-free treatment around the house or on-the-go. Because Capillus fits inside an ordinary hat, patients enjoy shame-free hair loss treatment with a level of discretion that is unparalleled. That’s an important advantage, according to experts at the Hair and Scalp Trichology Center. Hair loss is known to cause moderate to severe anxiety, fear, and depression among those it affects. By making the product discrete, Capillus has created a treatment option that patients enjoy using, which ultimately leads to a better user experience and results.
Capillus, LLC is based in the United States and conducts all manufacturing and quality control operations from company headquarters in Miami, Florida. Capillus is the first laser cap manufacturer to earn FDA clearance from the U.S. Food and Drug Administration for the treatment of androgenetic alopecia in men and women, an achievement that underscores the company’s commitment to patient safety and product efficacy.
“The clearance substantiates what we have known and experienced clinically,” says Capillus Medical Director, Dr. Shelly Friedman. “The Capillus laser cap is very successful in converting fine, vellus hairs to normal growing hairs. Our premarketing study for FDA clearance revealed a 51% increase in terminal (growing) hair counts over the placebo device.” Study details are made available online at ClinicalTrials.gov.
For product and distribution inquiries, UK surgeons, dermatologists, trichologists, and hair loss treatment clinics are invited to contact Mandy Baldwin at the Hair and Scalp Trichology Clinic online or by phone, 01322 27 33 00.
Frances Piña Brea, Capillus, http://www.capillus.com, +1 8442804648, [email protected]